Skip to content
GenoLensGenoLens

MVD

Chr 16q24.2

mevalonate diphosphate decarboxylase

Aliases:
MPD
MANE:
ENST00000301012.8

Annotations refreshed 10 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Familial disseminated superficial actinic porokeratosis

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Mosaic skin disorders - deep sequencing

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
  • Rare genetic inflammatory skin disorders

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown

Disease associations (Open Targets)

  • disseminated superficial actinic porokeratosis

    0.77
  • porokeratosis 7, multiple types

    0.68
  • neurodegenerative disease

    0.55
  • linear porokeratosis

    0.32
  • phototoxic dermatitis

    0.28
  • lysosomal storage disease

    0.27
  • stroke disorder

    0.15
  • alcohol drinking

    0.15
  • Varicose veins

    0.14
  • autosomal dominant nonsyndromic hearing loss

    0.11

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Diphosphomevalonate decarboxylase

Catalyzes the ATP dependent decarboxylation of (R)-5-diphosphomevalonate to form isopentenyl diphosphate (IPP). Functions in the mevalonate (MVA) pathway leading to isopentenyl diphosphate (IPP), a key precursor for the biosynthesis of isoprenoids and sterol synthesis

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.